These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

874 related items for PubMed ID: 18559335

  • 1. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L, Hua W, Niu H, Chen K, Zhang S.
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [Abstract] [Full Text] [Related]

  • 2. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ, Leman RB.
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.
    Arch Intern Med; 2009 Sep 14; 169(16):1500-6. PubMed ID: 19752408
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN.
    Rev Cardiovasc Med; 2001 Sep 14; 2(4):197-205. PubMed ID: 12439369
    [Abstract] [Full Text] [Related]

  • 6. A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator.
    Prystowsky EN.
    Rev Cardiovasc Med; 2003 Sep 14; 4 Suppl 2():S47-54. PubMed ID: 12776013
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.
    Sanders GD, Kong MH, Al-Khatib SM, Peterson ED.
    Am Heart J; 2010 Jul 14; 160(1):122-31. PubMed ID: 20598982
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M.
    Expert Rev Cardiovasc Ther; 2009 Feb 14; 7(2):181-95. PubMed ID: 19210214
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Cardiac resynchronization therapy-always with ICD?].
    Stellbrink C.
    Herz; 2005 Nov 14; 30(7):596-600. PubMed ID: 16333584
    [Abstract] [Full Text] [Related]

  • 12. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.
    Henyan NN, White CM, Gillespie EL, Smith K, Coleman CI, Kluger J.
    J Intern Med; 2006 Nov 14; 260(5):467-73. PubMed ID: 17040253
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.
    de Bie MK, Lekkerkerker JC, van Dam B, Gaasbeek A, van Buren M, Putter H, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ, Jukema JW.
    Curr Med Res Opin; 2008 Aug 14; 24(8):2151-7. PubMed ID: 18561878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Referring patients for consideration of device treatment of sudden cardiac death and heart failure: incorporating evidence-based therapies within the Canadian health care system.
    Gillis AM.
    Can J Cardiol; 2005 May 14; 21 Suppl A():25A-30A. PubMed ID: 15953941
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.